Berliner Boersenzeitung - US abortion ruling threatens access to arthritis drug

EUR -
AED 4.112593
AFN 71.669138
ALL 90.788645
AMD 403.584889
ANG 2.004261
AOA 1026.886761
ARS 1730.125816
AUD 1.626967
AWG 2.018499
AZN 1.898968
BAM 1.953851
BBD 2.257938
BDT 139.630746
BGN 1.957279
BHD 0.423174
BIF 3350.228885
BMD 1.119833
BND 1.431154
BOB 13.536379
BRL 6.164349
BSD 1.121082
BTN 105.855122
BWP 15.358546
BYN 3.34486
BYR 21948.730437
BZD 2.254631
CAD 1.572884
CDF 2592.413635
CHF 0.91398
CLF 0.027825
CLP 1095.106913
CNY 7.489999
CNH 7.464897
COP 3625.58312
CRC 508.388442
CUC 1.119833
CUP 26.904807
CVE 110.151702
CZK 24.350217
DJF 199.630907
DKK 7.474383
DOP 67.322258
DZD 152.570958
EGP 60.270991
ERN 16.797498
ETB 183.994359
FJD 2.531983
FKP 0.830529
GBP 0.834091
GEL 2.917144
GGP 0.830529
GHS 13.076842
GIP 0.830529
GMD 83.428936
GNF 9929.875211
GTQ 8.567188
GYD 234.883652
HKD 8.775069
HNL 30.130681
HRK 7.580162
HTG 146.922162
HUF 364.716191
IDR 20314.89382
ILS 3.59355
IMP 0.830529
INR 105.468691
IQD 1699.489915
IRR 2117999.855204
ISK 136.799392
JEP 0.830529
JMD 177.81108
JOD 0.793902
JPY 176.727036
KES 145.477209
KGS 97.928631
KHR 4561.450846
KMF 493.84599
KPW 1007.849824
KRW 1523.141376
KWD 0.347775
KYD 0.934256
KZT 504.060546
LAK 25230.499556
LBP 100678.36257
LKR 372.693319
LRD 190.577384
LSL 18.370876
LTL 3.306576
LVL 0.677376
LYD 7.176843
MAD 10.925007
MDL 20.043027
MGA 5082.885427
MKD 61.549404
MMK 2351.596988
MNT 4033.608062
MOP 9.058585
MRU 45.290427
MUR 52.665738
MVR 17.307015
MWK 1943.943937
MXN 21.013656
MYR 4.54596
MZN 71.568673
NAD 18.371532
NGN 1505.481108
NIO 41.257932
NOK 10.448884
NPR 169.371573
NZD 2.013701
OMR 0.430574
PAB 1.121072
PEN 3.861449
PGK 5.106861
PHP 70.608858
PKR 310.053613
PLN 4.40375
PYG 6907.111508
QAR 4.097785
RON 5.336121
RSD 117.64746
RUB 91.267205
RWF 1651.338367
SAR 4.203464
SBD 9.016581
SCR 15.530541
SDG 673.57461
SEK 11.01693
SGD 1.433806
SHP 0.834886
SLE 25.654803
SLL 23482.34691
SOS 640.655351
SRD 42.057597
STD 23178.286007
STN 24.475372
SVC 9.809086
SYP 14560.070726
SZL 18.364521
THB 37.54073
TJS 10.341648
TMT 3.930614
TND 3.340464
TOP 2.696289
TRY 56.152239
TTD 7.592326
TWD 36.884021
TZS 2966.696034
UAH 50.924158
UGX 4534.437294
USD 1.119833
UYU 45.154765
UZS 13377.539063
VES 1000.872181
VND 28676.1283
VUV 133.835028
WST 3.111473
XAF 655.957
XAG 0.021762
XAU 0.000276719297
XCD 3.026405
XCG 2.020367
XDR 0.79178
XOF 655.957
XPF 119.331742
YER 264.476607
ZAR 18.50484
ZMK 10079.847437
ZMW 22.729129
ZWL 360.585829
SSP 6433.66131
MXV 2.364121
  • CMSD

    -0.1200

    19.81

    -0.61%

  • JRI

    0.0000

    10.77

    0%

  • BCC

    -1.8200

    74.15

    -2.45%

  • CMSC

    -0.2228

    19.53

    -1.14%

  • BCE

    0.2000

    20.34

    +0.98%

  • RIO

    0.0100

    94.17

    +0.01%

  • AZN

    -2.7400

    161.47

    -1.7%

  • GSK

    -1.1800

    48.17

    -2.45%

  • RBGPF

    0.0000

    65

    0%

  • NGG

    0.8800

    75.82

    +1.16%

  • RYCEF

    -0.7300

    19.08

    -3.83%

  • BTI

    -0.4500

    54.4

    -0.83%

  • BP

    0.4700

    43.99

    +1.07%

  • RELX

    -0.0600

    33.18

    -0.18%

  • VOD

    -0.1800

    16.15

    -1.11%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: Andy Buchanan - POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

(S.G.Stein--BBZ)